blocked randomisation method (Amgen)
Structured Review

Blocked Randomisation Method, supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/blocked+randomisation+method/randomisation+lists/pmc10445271-186-25-20
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "TPO receptor agonist for chronic idiopathic thrombocytopenic purpura"
Article Title: TPO receptor agonist for chronic idiopathic thrombocytopenic purpura
Journal: The Cochrane Database of Systematic Reviews
doi: 10.1002/14651858.CD008235.pub2
Figure Legend Snippet: Kuter 2008a
Techniques Used: Sequencing, Selection, Generated, Sterility, Injection
Figure Legend Snippet: Kuter 2008b
Techniques Used: Sequencing, Selection, Generated, Sterility, Injection
Related Articles
other:Article Title: Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Article Snippet: David J Kuter, James B Bussel, Roger M Lyons, Vinod Pullarkat, Terry B Gernsheimer, Francis M Senecal, Louis M Aledort, James N George, Craig M Kessler, Miguel A Sanz, Howard A Liebman, Frank T Slovick, J Th M de Wolf, Emmanuelle Bourgeois, Troy H Guthrie Jr, Adrian Newland, Jeff rey S Wasser, Solomon I Hamburg, Carlos Grande, François Lefrère, Alan Eli Lichtin, Michael D Tarantino, Howard R Terebelo, Jean-François Viallard, Francis J Cuevas, Ronald S Go, David H Henry, Robert L Redner, Lawrence Rice, Martin R Schipperus, D Matthew Guo, Janet L Nichol Sequencing:Article Title: TPO receptor agonist for chronic idiopathic thrombocytopenic purpura Article Snippet: .. Random sequence generation (selection bias) , Low risk , A ‐ Adequate. Quote: "The random allocation sequence was generated by Amgen Inc with the blocked Selection:Article Title: TPO receptor agonist for chronic idiopathic thrombocytopenic purpura Article Snippet: .. Random sequence generation (selection bias) , Low risk , A ‐ Adequate. Quote: "The random allocation sequence was generated by Amgen Inc with the blocked Generated:Article Title: TPO receptor agonist for chronic idiopathic thrombocytopenic purpura Article Snippet: .. Random sequence generation (selection bias) , Low risk , A ‐ Adequate. Quote: "The random allocation sequence was generated by Amgen Inc with the blocked |